Skip to main content

Table 2 Relationship between the level of MDA-LDL and various parameters in univariate analyses

From: Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease

 

r

p

Age

0.010

0.887

Body mass index

−0.023

0.739

Waist circumference

0.025

0.724

Systolic blood pressure

0.075

0.281

Creatinine

0.036

0.600

Hemoglobin A1c

0.068

0.330

LDL cholesterol

0.458

<0.0001

Triglycerides*

0.435

<0.0001

HDL cholesterol

−0.164

0.017

Adiponectin*

−0.227

0.001

  1. Abbreviations: HDL high-density lipoprotein, LDL low-density lipoprotein, MDA-LDL malondialdehyde-modified LDL.
  2. Statistical analyses were performed using simple regression.
  3. *Log-transformed values were subjected to statistical analyses.
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us